Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL.

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

President Donald Trump on Wednesday moved to dislodge a cornerstone of modern civil rights law through a sweeping executive order that strips the federal government of the key tool it used to ...

Current evidence overstates the impact of eco-labels on food products and menus. But it doesn’t mean we should stop using ...